CeleCor Therapeutics, Inc., 2026-07-09
An SEC Form D private-offering notice from Del Mar, CA, a $15,000,000 filer-stated offering target in Biotech. Filed 2026-07-09. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage pharmaceutical company developing zalunfiban, a pre-hospital anti-platelet drug for STEMI heart attacks
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Harvest AI, Inc., 2026-07-10, $11M, Emeryville, CA
- Silo Pharma, Inc., 2026-07-14, $4M, Sarasota, FL
- Vantis Vascular, Inc., 2026-07-10, $21.5M, San Jose, CA
- Pluristyx Inc., 2026-07-13, $14.8M, Seattle, WA
- Glydways, Inc., 2026-07-09, $60M, South San Francisco, CA
- Skybound Medtech Inc., 2026-07-09, $1.2M, Houston, TX
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.